MetLife has delivered a strong multi year share price run, and the question now is whether that market enthusiasm is fully backed by the returns the insurer earns on its capital. With the stock recently closing at US$102.89, investors are weighing how much of the value of its capital base is already reflected in that price.
- Over the past 3 years the stock has returned 88.9%, which puts real weight on whether the underlying return on capital profile can support that kind of re rating.
- A recently approved C$213.5 million settlement related to universal life policies sold by MetLife agents in Canada may influence how investors think about future capital allocation and potential claims costs when they assess the value created on each dollar of equity.
- What if you looked at MetLife through its earnings instead? See why MetLife's 19.0x P/E tells a different valuation story.
The issue now is whether the returns MetLife earns on its capital base are strong enough and durable enough to justify where the share price trades today.
To see how MetLife compares with other insurers where the discussion also focuses on the returns they earn on capital, browse the 31 resilient stocks with low risk scores.
Does MetLife Look Undervalued on Excess Returns?
The Excess Returns model looks at how much profit MetLife generates above its cost of equity, rather than just projecting cash flows. MetLife is shown with a Book Value of $43.03 per share and a Stable EPS of $8.39 per share, which implies a solid earnings stream on the equity invested in the business.
The model uses a Cost of Equity of $3.87 per share and an Excess Return of $4.51 per share, alongside an Average Return on Equity of 16.16% and a Stable Book Value of $51.92 per share. Together, these inputs point to an estimated intrinsic value that is substantially above the current share price of $102.89. The recently approved C$213.5 million settlement linked to universal life policies sold by MetLife agents in Canada helps explain why the market may still apply some caution, even though the model indicates higher value based on ongoing returns on equity. Find out what MetLife could be worth using our Excess Returns estimate.
The MetLife Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for MetLife pick up where this valuation puzzle leaves off and spell out which paths for growth, profitability and earnings would need to play out for the stock to be worth materially more or less than today’s price, using the Community page as home base for those scenarios. Each one links its number to a specific view on how MetLife's growth, margins and risk profile might evolve, giving you something concrete to revisit as new information emerges.
One of the top community narratives on MetLife: roughly fairly valued
"Analysts expect MetLife to keep using its balanced mix of capital-light operations and retirement businesses to support earnings quality and capital flexibility..."
Discover why this Narrative puts MetLife at roughly fairly valued.
One more angle on MetLife that could change the story
Before moving on, it is worth asking who is steering MetLife, how their incentives are structured, and whether those pay packets truly line up with the outcomes you care about. See who runs MetLife and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com